CME Credits: 0.25
Type 2 diabetes management in 2023
In this podcast series we explore hot topics in T2D including appropriate therapy targets, matching patients to specific agents, and discussing the effect of cultural and religious values
Endocrinologist, Brigham and Women's Hospital, USA
Vanita Aroda is the Director of Diabetes Clinical Research at the Brigham and Women's Hospital in Boston, MA, and is an Associate Professor of Medicine at Harvard Medical School. Dr. Aroda completed her training in Internal Medicine and in Endocrinology, Diabetes and Metabolism at the University of California San Diego, CA, USA.
Dr. Aroda has an interest and published record in diabetes prevention and novel therapeutics in diabetes and weight management. She also has a strong interest in understanding therapeutic interventions in large multicenter clinical trials and their applicability and integration into care. Dr. Aroda has years of experience in clinical trial conduct and leadership, has served as an investigator on the National Institutes of Health-funded GRADE, D2d, and DPPOS studies, and as the national or international signatory Principal Investigator for multiple therapeutic clinical trials. Dr. Aroda served on the Professional Practice Committee of the American Diabetes Association (Standards of Care in Diabetes 2021, 2022, 2023) and on the international 2022 ADA-EASD Consensus Group for the Management of Hyperglycemia in Type 2 Diabetes.
In this podcast series we explore hot topics in T2D including appropriate therapy targets, matching patients to specific agents, and discussing the effect of cultural and religious values
With Dr Richard Pratley and Dr Vanita Aroda